Enzistal-P - instructions for use, doses, side effects, contraindications

Auxiliary matter: lactose monohydrate 44.83 mg, microcrystalline cellulose 168.00 mg, magnesium stearate 4.00 mg, silicon dioxide colloidal 2.00 mg, sodium carboxymegil starch 15.00 mg.

Sheath: hypromellose 6,10 mg, macrogol 6000 0.61 mg, titanium dioxide 2.91 mg, acetate phthalate cellulose 25.00 mg, diethyl phthalate 4.50 mg, azorubin (carmosein) 0.78 mg, beeswax white 0.10 mg.

Description:Pink round biconvex tablets, covered with enteric coating.

Pharmacotherapeutic group:digestive enzyme.

ATX: & nbsp

A.09.A.A Enzyme preparations

A.09.A.A.02 Pancreatin

Pharmacodynamics:

Digestive enzymatic means compensates deficiency of pancreatic enzymes, having a proteolytic, amylolytic and lipolytic action. Included in the composition of pancreatic enzymes (lipase, alpha-amylase, trypsin, chymotrypsin) Contribute to the breakdown of proteins to amino acids, fats - to glycerol and fatty acids, starch - into dextrins and sugars, improves the functional state of the gastrointestinal tract, facilitates the rapid and complete digestion, alleviates the symptoms arising from digestive disorders (removes heavy feeling and fullness in the stomach; flatulence, diarrhea), normalizes the digestive process. Trypsin suppresses the stimulated secretion of the pancreas, providing analgesic effect. Pancreatic enzymes are released from the dosage form in the alkaline medium of the small intestine. protected from the action of gastric juice shell.

Indications:

Substitution treatment for exocrine pancreatic insufficiency: chronic pancreatitis, pancreatectomy, post-irradiation,

dyspepsia, cystic fibrosis, flatulence, diarrhea of non-infectious genesis.

Disturbance of the assimilation of food (state after resection of the stomach and small intestine);

DTo improve the digestion of food in individuals with normal gastrointestinal function in the event of nutritional errors (eating fatty foods, large amounts of food, irregular meals) and in cases of malfunctioning, sedentary lifestyle, prolonged immobilization.

Remkheld's syndrome (gastrocardial syndrome).

Preparation and X-ray and ultrasound of the abdominal organs.

Contraindications:

Hypersensitivity to the components of the drug, acute pancreatitis, exacerbation of chronic pancreatitis, children under 3 years.

Pregnancy and lactation:

During pregnancy and lactation, the drug is prescribed only if the expected benefit to the mother exceeds the potential risk to the fetus or child.

Dosing and Administration:

Enzistal®-P is taken orally, without chewing, during or immediately after eating, with plenty of liquid.

The average dose for adults is 1-2 tablets at the beginning of the meal.

Depending on the degree of pancreatic insufficiency and the quality and quantity of food consumed, the dose can be increased to 2-4 tablets at the beginning of the meal.Higher doses are prescribed by the doctor. The maximum daily dose is 15-20 thousand AD / kg (in terms of lipase). To children the dose is picked up by the doctor. Usually prescribed 1 tablet 3 times a day during meals.

Duration of treatment can vary from several days (with digestion disorders inaccuracy in the diet) to several months and even years (if necessary, permanent replacement therapy).

Side effects:

Allergic reactions, rarely - diarrhea or constipation, nausea, discomfort in the epigastric region. With prolonged use in high doses, hyperuricosuria, when high doses are used in patients with cystic fibrosis, strictures in the ileocecal region and in the ascending colon.

Overdose:Symptoms: hyperuricosuria, hyperuricemia. Children have constipation. Treatment: withdrawal of the drug, symptomatic therapy.

Interaction:

With simultaneous application with Enzistal®-P, it is possible to reduce the absorption of iron preparations.

Form release / dosage:Tablets, covered with enteric coating.

Packaging:

10 tablets in Al / Al. blister. 1, 2, 4 or 8 blisters for 10 tablets with instructions for use are packed in a cardboard box.

Storage conditions:

Store at a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Shelf life:

3 years. Do not use after the expiry date printed on the package.

Terms of leave from pharmacies:Without recipe

Registration number:LSR-002667/08

Date of registration:10.04.2008

The owner of the registration certificate:Torrent Pharmaceuticals Co., Ltd.Torrent Pharmaceuticals Co., Ltd. India

Manufacturer: & nbsp

TORRENT PHARMACEUTICALS, Ltd. India

Representation: & nbspTORRENT PHARMACEUTICALS LTD. TORRENT PHARMACEUTICALS LTD. India

Information update date: & nbsp19.08.2015

Illustrated instructions

Instructions

Enzistal®-P (Enzystal®-P)